Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 2
1993 2
1996 2
1997 3
1998 1
1999 3
2000 4
2001 1
2002 6
2003 5
2004 5
2005 4
2008 3
2009 1
2010 2
2011 5
2012 2
2013 3
2014 6
2015 6
2016 7
2017 11
2018 8
2019 3
2020 7
2021 6
2022 3
2023 8
2024 8
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Börjesson Sjö L, Fan Y, Jison M, McCrae C, Necander S, Shavit A, Walton C, Merkel PA; MANDARA Study Group. Wechsler ME, et al. N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. N Engl J Med. 2024. PMID: 38393328 Clinical Trial.
Sounding the alarmins-The role of alarmin cytokines in asthma.
Gauvreau GM, Bergeron C, Boulet LP, Cockcroft DW, Côté A, Davis BE, Leigh R, Myers I, O'Byrne PM, Sehmi R. Gauvreau GM, et al. Among authors: sehmi r. Allergy. 2023 Feb;78(2):402-417. doi: 10.1111/all.15609. Epub 2022 Dec 14. Allergy. 2023. PMID: 36463491 Free PMC article. Review.
Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trial.
Gauvreau GM, Sehmi R, FitzGerald JM, Leigh R, Cockcroft DW, Davis BE, Mayers I, Boulet LP, Al-Sajee D, Salter BM, Cusack RP, Ho T, Whetstone CE, Alsaji N, Satia I, Killian KJ, Mitchell PD, Magee IP, Bergeron C, Bhutani M, Werkström V, Durżyński T, Shoemaker K, Katial RK, Jison M, Newbold P, McCrae C, O'Byrne PM. Gauvreau GM, et al. Among authors: sehmi r. Eur Respir J. 2024 Sep 12;64(3):2400512. doi: 10.1183/13993003.00512-2024. Print 2024 Sep. Eur Respir J. 2024. PMID: 39060015 Free PMC article. Clinical Trial.
Clinical Remission by a Comprehensive Severe Asthma Management Strategy Guided by Airway Inflammometry and Bioimaging.
Nolasco S, Kjarsgaard M, Lauks S, Treleaven O, Ho T, Huang C, Radford K, Swindall T, Venegas Garrido C, Bhalla A, Thawanaphong S, Friedlander Y, Dyment L, Surette M, Trus M, Sehmi R, Haider E, Khalidi N, Sommer DD, Waserman S, Mukherjee M, Svenningsen S, Cox G, Nair P. Nolasco S, et al. Among authors: sehmi r. Am J Respir Crit Care Med. 2025 Sep;211(9):1622-1635. doi: 10.1164/rccm.202412-2438OC. Am J Respir Crit Care Med. 2025. PMID: 40540629
Hematopoietic Processes in Eosinophilic Asthma.
Salter BM, Sehmi R. Salter BM, et al. Among authors: sehmi r. Chest. 2017 Aug;152(2):410-416. doi: 10.1016/j.chest.2017.01.021. Epub 2017 Jan 24. Chest. 2017. PMID: 28130045 Review.
Benralizumab Normalizes Sputum Eosinophilia in Severe Asthma Uncontrolled by Anti-IL-5 Antibodies: A Single-Blind, Placebo-controlled Clinical Trial.
Mukherjee M, Huang C, Venegas-Garrido C, Zhang K, Bhalla A, Ju X, O'Byrne PM, Svenningsen S, Sehmi R, Nair P. Mukherjee M, et al. Among authors: sehmi r. Am J Respir Crit Care Med. 2023 Dec 15;208(12):1330-1335. doi: 10.1164/rccm.202308-1413LE. Am J Respir Crit Care Med. 2023. PMID: 37824744 Clinical Trial. No abstract available.
TNF Superfamily and ILC2 Activation in Asthma.
Matsuyama T, Salter BM, Emami Fard N, Machida K, Sehmi R. Matsuyama T, et al. Among authors: sehmi r. Biomolecules. 2024 Feb 29;14(3):294. doi: 10.3390/biom14030294. Biomolecules. 2024. PMID: 38540714 Free PMC article. Review.
123 results